Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

China flag China · Delayed Price · Currency is CNY
65.21
+0.38 (0.59%)
Sep 5, 2025, 2:45 PM CST
0.59%
Market Cap51.06B
Revenue (ttm)4.51B
Net Income (ttm)1.70B
Shares Out785.72M
EPS (ttm)2.16
PE Ratio30.10
Forward PE27.28
Dividend1.30 (2.00%)
Ex-Dividend DateMay 28, 2025
Volume7,080,046
Average Volume6,551,079
Open58.70
Previous Close64.83
Day's Range58.70 - 65.50
52-Week Range49.01 - 97.20
Beta-0.48
RSI70.86
Earnings DateAug 26, 2025

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China. [Read more]

Sector Healthcare
Founded 1995
Employees 2,841
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300832
Full Company Profile

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.